AI tool for measuring breast density added to ACR platform

Artificial intelligence developer Whiterabbit.ai announced it’s teaming up with the American College of Radiology’s Data Science Institute (ACR) to facilitate the assessment of breast density and ultimately improve screening for, and treatment of, breast cancer.

The collaboration will ensure Whiterabbit’s WRDDensity, an AI-powered breast density measurement tool, is available on the ACR’s AI-Lab platform, a statement on the collaboration said. AI-Lab was developed by ACR to make it easier for radiologists to leverage AI tools as part of their workflows. 

“ACR’s AI-LAB will use WRDensity in its objective to simplify the evaluation and adoption of AI for uses such as breast density assessment. In turn, this could empower radiologists to develop algorithms at their own institutions to meet their unique clinical needs," said Laura Coombs, vice president of data science and informatics at ACR, said in the statement. "ACR DSI facilitates the development, validation and implementation of artificial intelligence applications to expand radiologists’ diagnostic and clinical capabilities to improve medical care.”

Whiterabbit added that the goal of adding WRDensity to the AI-Lab platform is to improve care delivery, emphasizing that the assessment of breast density is a crucial part of identifying breast cancer and developing effective treatments.

WRDensity is the FDA-cleared, commercial AI application for measuring breast density to be added to the AI-Lab platform.

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.